Literature DB >> 6119148

Effect of prostaglandins on rat heart sarcolemmal ATPases.

M Karmazyn, B S Tuana, N S Dhalla.   

Abstract

The ability of prostaglandins (PG) D2, E1, E2, F2 alpha and I2 (2.8 X 10(-11) to (2.8 X 10(-7) M) to modify Ca2+, Mg2+ and (Na+ + K+)-ATPase activities of rat heart sarcolemmal membrane fractions was examined. Administration of PGE2, PGF2 alpha, and PGI2 reduced basal (Na + + K+)-ATPase activity by up to 30, 80, and 80%, respectively. PGE1 and PGD2 were ineffective at any concentration. Neither Mg2+ -ATPase nor Ca2+ -ATPase was affected by PG treatment. Kinetic analysis revealed that the (Na+ + K+)-ATPase activity reducing ability of PGE2, PGF2 alpha and PGI2 was of a complex nature involving a reduction in Vmax and an elevation of the respective K values for either substrate or activator. These results demonstrate that some PG's are potent inhibitors of rat heart (Na+ + K+)-ATPase. These PG's produced varied inotropic influences on isolated heart preparations and it is uncertain whether their myocardial actions are dependent on enzyme inhibition.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6119148     DOI: 10.1139/y81-173

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  3 in total

Review 1.  Significance of myocardial eicosanoid production.

Authors:  M van Bilsen; W Engels; G J van der Vusse; R S Reneman
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

2.  The influence of prostacyclin (PGI2) on contractile properties of isolated right ventricle of rat heart.

Authors:  M Pavlović; D Petković; M Cvetković; D J Macut; K Zdjelar; M Nesić; O Bosnić; R Radulović; M Mihajlović
Journal:  Experientia       Date:  1995-09-29

3.  The composition of cardiac phospholipids in rats fed different lipid supplements.

Authors:  J S Charnock; M Y Abeywardena; E J McMurchie; G R Russell
Journal:  Lipids       Date:  1984-03       Impact factor: 1.880

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.